Cyclin E2 (CCNE2) Antibody

Product Graph
260€ (50 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Cyclin E2 (CCNE2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx210917
tested applications
ELISA, IHC

Description

CCNE2 Antibody is a Rabbit Polyclonal against CCNE2.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Cyclin E2 (CCNE2)
Host
Rabbit
Reactivity
Human
Recommended Dilution
ELISA: 1/2000 - 1/5000, IHC: 1/50 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Antigen Affinity Chromatography.
Size 1
50 µl
Size 2
100 µl
Form
Liquid
Tested Applications
ELISA, IHC
Buffer
PBS, pH 7.4, containing 0.05% NaN3 and 40% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
O96020
Gene ID
9134
Background
Antibody anti-CCNE2
Status
RUO

Descripción

Related Products

FNab10611

CCNE2 antibody

Ver Producto
P2440

Recombinant Human CCNE2

Ver Producto
abx003169

Cyclin E2 (CCNE2) Antibody

CCNE2 Antibody is a Rabbit Polyclonal antibody against CCNE2. The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK2. This cyclin has been shown to specifically interact with CIP/KIP family of CDK inhibitors, and plays a role in cell cycle G1/S transition. The expression of this gene peaks at the G1-S phase and exhibits a pattern of tissue specificity distinct from that of cyclin E1. A significantly increased expression level of this gene was observed in tumor-derived cells.

Ver Producto